Khaled Musallam: De-LIGHT Study Reveals Age-Related Multisystem Morbidity in β-Thalassemia
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haematologica, adding:
“Pleased to share our new study out today in Haematologica:
‘β-thalassemia as a progressive disease: age-related morbidity in the de-LIGHT study.’
Our findings highlight an important shift in how we think about β-thalassemia: as patients live longer, multisystem morbidity progressively accumulates across the lifespan, in both transfusion-dependent and non-transfusion-dependent disease.
These data reinforce the importance of lifelong disease control, age-adapted surveillance, and (hopefully when available) earlier use of disease-modifying approaches before irreversible complications develop.”
Title: β-thalassemia as a progressive disease: age-related morbidity in the de-LIGHT study
Authors: Khaled M. Musallam, Angela Vitrano, Alessandro Inzerillo, Rosario Di Maggio, Rita Barone, Antonino Giangreco, Maria Concetta Renda, Emanuela Fecarotta, Antonio Troia, Antonino Giambona, Giovan Battista Ruffo, Efthymia Vlachaki, Theodora M. Venou, Paolo Ricchi, Brunella Ziello, Marilena Serra, Elena Colizzi, Filomena Longo, Martina Culcasi, Aurelio Maggio
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 2, 2026, 12:31Ahmed Salah El-Deen: HELLP Syndrome – An Obstetric Emergency
-
Oct 2, 2026, 12:28Swapnil Hiremath: Transitioning from Idiopathic Thrombocytopenia to Antiphospholipid Syndrome in Recurrent Severe Preeclampsia
-
Oct 2, 2026, 12:08Austin Camp: Learn How to Treat HIT from an ICU Pharmacist in 60 Seconds!
-
Oct 2, 2026, 12:02Fahad Laghari: Flow Diversion for a Cavernous Internal Carotid Artery Aneurysm
-
Oct 2, 2026, 12:02Archil Jaliashvili: Exploring BHOC as a Complementary Oxygen-Delivery Strategy
-
Oct 2, 2026, 11:57Cornelia Elena Predoi: Peri-Interventional Prophylactic Plasma Transfusion in Anaesthesia and Critical Care
-
Oct 2, 2026, 11:41Daniel Pereira Monteiro: Why HbA1c Fails in Hemoglobinopathies – Modern Glycemic Monitoring and Therapeutic Approaches
-
Oct 2, 2026, 11:20Chris Baugh: Modern ED Strategies for Antithrombotic-Associated Bleeding
-
Oct 2, 2026, 09:20Anticoagulants, Blood Thinners, or Antithrombotic Medications? – World Thrombosis Day